SUBSCRIBE
SUBSCRIBE

Sarepta Therapeutics, Inc.

NEWS
M&A Speculation Begins as Sarepta CEO Puts In His Notice
Job Trends
Sarepta’s New Facility to Open in Early 2017, Plans to Hire 45 New Staffers
November 4, 2016
 · 
2 min read
This Is Why Woodcock OKed Sarepta's DMD Drug
FDA
This Is Why Woodcock OKed Sarepta’s DMD Drug
November 4, 2016
 · 
3 min read
M&A Speculation Begins as Sarepta CEO Puts In His Notice
Genetown
Humana to Cover Sarepta’s Controversial DMD Drug But There’s a Catch
October 27, 2016
 · 
2 min read
What You Missed: Nippon Fine Chemical Formed Human Barricade to Stop FDA Employee
FDA
Sarepta Gets No Love From the FDA’s New Drugs Director
October 20, 2016
 · 
3 min read
BioCapital
SunTrust Managing Director Goes Over Sarepta’ Story
October 18, 2016
 · 
1 min read
Policy
PTC Therapeutics Wants a Slice of Sarepta’s DMD Pie, Says Rejected Drug May Help Some Patients
October 7, 2016
 · 
1 min read
M&A Speculation Begins as Sarepta CEO Puts In His Notice
Business
Sarepta Goes for a New DMD Combo With New $562 Million+ Deal With Summit Therapeutics
October 4, 2016
 · 
2 min read
Policy
After Sarepta’s Win, BioMarin Wants a Piece of the Action Too
September 23, 2016
 · 
1 min read
M&A Speculation Begins as Sarepta CEO Puts In His Notice
Drug Development
Saga Continues for Sarepta as FDA Head Calls for Retraction of ‘Misleading’ 2013 Study
September 23, 2016
 · 
3 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2024 Best Places to Work
JOBS
IN THE PRESS
Press Releases
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 30, 2026
July 1, 2026
 · 
1 min read
Press Releases
Sarepta Announces FDA Acceptance of sNDAs for AMONDYS 45® and VYONDYS 53®
June 30, 2026
 · 
17 min read
Press Releases
Sarepta Therapeutics to Participate in Upcoming Investor Conferences
June 2, 2026
 · 
1 min read
Press Releases
Sarepta Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference
May 14, 2026
 · 
1 min read
Press Releases
Sarepta Therapeutics Announces First Quarter 2026 Financial Results and Recent Corporate Developments
May 7, 2026
 · 
19 min read
Press Releases
Sarepta Therapeutics to Announce First Quarter 2026 Financial Results
April 23, 2026
 · 
1 min read
Press Releases
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 31, 2026
April 1, 2026
 · 
1 min read
Press Releases
Sarepta Announces First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1
March 25, 2026
 · 
9 min read
Press Releases
Sarepta to Share First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1
March 25, 2026
 · 
1 min read
Press Releases
Sarepta Provides Regulatory Update on AMONDYS 45® and VYONDYS 53®
March 19, 2026
 · 
15 min read
Load More